SCHEMBL1490345

SCHEMBL1490345

Cn1cc2ccc(NC(=O)c3cccnc3NCc3ccnc(NC(=O)N4CCOCC4)c3)cc2n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.51
KDR P35968 13/20 0.43
CIT O14578 1/20 0.43
MAP3K7 O43318 1/20 0.43
RIPK2 O43353 1/20 0.43
STK10 O94804 1/20 0.43
MAP4K4 O95819 1/20 0.43
ABL1 P00519 1/20 0.43
EGFR P00533 1/20 0.43
RAF1 P04049 1/20 0.43
LCK P06239 1/20 0.43
FYN P06241 1/20 0.43
CSF1R P07333 1/20 0.43
YES1 P07947 1/20 0.43
LYN P07948 1/20 0.43
RET P07949 1/20 0.43
HCK P08631 1/20 0.43
PDGFRB P09619 1/20 0.43
FGR P09769 1/20 0.43
KIT P10721 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1490859 0.85 KIT (0.50) ABCB1KDRCITMAP3K7RIPK2
SCHEMBL1490758 0.85 KDR (0.47) ABCB1KDRCITMAP3K7RIPK2
SCHEMBL13714573 0.83 IRAK4 (0.39) KITBRAFKDM4EAURKARPS6KB1
SCHEMBL1490691 0.83 KDR (0.45) ABCB1KDRCITMAP3K7RIPK2
SCHEMBL13714564 0.83 KIT (0.49) KDRKITBRAFFLT1
SCHEMBL1490582 0.82 KDR (0.55) ABCB1KDRCITMAP3K7RIPK2
SCHEMBL5176609 0.82 KDR (0.50) ABCB1KDRCITMAP3K7RIPK2
SCHEMBL13714592 0.81 KIT (0.50) KITBRAF
SCHEMBL13714601 0.81 KIT (0.48) KDRKITBRAFFLT1
SCHEMBL3866092 0.81 KIT (0.50) KITBRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807416-B1 Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors Bayer Pharma AG (DE) 2012-08-29 EP disclosed
US-7906533-B2 Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors BAYER SCHERING PHARMA AG (DE) 2011-03-15 US disclosed
US-7906533-B2 Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors BAYER SCHERING PHARMA AG (DE) 2011-03-15 US disclosed
US-7906533-B2 Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors BAYER SCHERING PHARMA AG (DE) 2011-03-15 US disclosed